MAM
SGMO

Meeder Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Meeder Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,850
Closed -$34K – 2350
2020
Q2 		$34K Buy
3,850
+2,527
+191% +$23.4K ﹤0.01% 1002
2020
Q1 		$8K Buy
1,323
+589
+80% +$4.37K ﹤0.01% 1626
2019
Q4 		$6K Buy
734
+210
+40% +$1.93K ﹤0.01% 1736
2019
Q3 		$5K Buy
+524
New +$5.88K ﹤0.01% 1773
2019
Q2 		– Sell
-201
Closed -$2K – 2131
2019
Q1 		$2K Sell
201
-537
-73% -$5.49K ﹤0.01% 1569
2018
Q4 		$8K Buy
738
+587
+389% +$7.29K ﹤0.01% 1310
2018
Q3 		$3K Sell
151
-509
-77% -$7.74K ﹤0.01% 1411
2018
Q2 		$9.37K Sell
660
-769
-54% -$12.8K ﹤0.01% 1136
2018
Q1 		$27K Buy
1,429
+556
+64% +$11.9K ﹤0.01% 814
2017
Q4 		$14K Buy
873
+590
+208% +$8.78K ﹤0.01% 1047
2017
Q3 		$4K Sell
283
-309
-52% -$3.42K ﹤0.01% 1332
2017
Q2 		$5K Sell
592
-839
-59% -$5.38K ﹤0.01% 1207
2017
Q1 		$7K Sell
1,431
-2,773
-66% -$11.1K ﹤0.01% 962
2016
Q4 		$13K Buy
+4,204
New +$15.3K ﹤0.01% 713

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meeder Asset Management's SGMO Position: Q3 2020 in Review

Meeder Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2020, closing a stake of 3,850 shares — an estimated $34K sold.

Meeder Asset Management first reported a position in SGMO in Q4 2016 and held it in 14 quarters. The position peaked at $34K in Q2 2020. 210 funds tracked by Wall St. Rank hold SGMO as of Q3 2020.

  • Meeder Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2020 after selling out during the quarter.
  • Meeder Asset Management sold 3,850 SANGAMO THERAPEUTICS INC shares in Q3 2020, an estimated $34K.
  • Meeder Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and held it in 14 quarters.
  • Meeder Asset Management's SANGAMO THERAPEUTICS INC position peaked at $34K in Q2 2020.
  • 210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.